Results 191 to 200 of about 326,606 (289)

Correction to "Psychosocial Nursing Diagnoses of Individuals With Myalgic Encephalomyelitis-Chronic Fatigue Syndrome: A Descriptive Study". [PDF]

Nurs Open
europepmc   +1 more source

Effectiveness and safety of exercise therapy in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a meta-analysis. [PDF]

Front Neurol
Wei Z, Wu H, Cui C, Wang Z, Xiong H, Song F, Ren J.   +6 more
europepmc   +1 more source

Weekly Subcutaneous VK2735, a GIP/GLP‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study

Obesity, EarlyView.
Four doses of VK2735 and a placebo group were included in the VENTURE study. Adults who were overweight or had obesity had significant weight loss when taking any dose of VK2735 for 13 weeks. More people lost at least 10% of their body weight as the dose increased.
Harold E. Bays, Phillip Toth, Naim Alkhouri, John Pullman, Bradley Freilich, Joel Neutel, Summer Ji, Scott Stubbe, Parke Hedges, Brian Lian   +9 more
wiley   +1 more source

Brain fog in Parkinson's disease: unraveling mechanisms and measuring impact. [PDF]

Front Neurol
Elliott TR, Valencia X, Chen S, Matta A.
europepmc   +1 more source

How do Patient Comorbidities Influence Adult Cochlear Implant Outcomes?

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To evaluate the relationship between weighted comorbidity indices and post‐cochlear implant (CI) speech recognition and patient‐reported outcome measures (PROMs). Study Design Retrospective cohort. Setting Tertiary Neurotology Center.
Barak Spector, Tam Nguyen, Priya Bandaru, Sandra Simmons, Aaron C. Moberly, Terrin N. Tamati   +5 more
wiley   +1 more source

Large-scale investigation confirms TRPM3 ion channel dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. [PDF]

Front Med (Lausanne)
Sasso EM, Er TS, Eaton-Fitch N, Hool L, Muraki K, Marshall-Gradisnik S.   +5 more
europepmc   +1 more source

Sustained illness burden over time among Australians with myalgic encephalomyelitis/chronic fatigue syndrome. [PDF]

PLoS One
Weigel B, Eaton-Fitch N, Thapaliya K, Marshall-Gradisnik S.   +3 more
europepmc   +1 more source

The General Disease Factor (“d”): First Empirical Evidence From China

Med Research, EarlyView.
Hongyi Sun, Qinghuan He, Ting Su, Xiaoli Yang, Zhiwei Zhou   +4 more
wiley   +1 more source

Exploration of the Phytochemical and Antidiabetic Properties of Teucrium polium: A Natural Asset for Type 2 Diabetes Management

ChemistryOpen, EarlyView.
Teucrium polium shows antidiabetic activity with its phytochemical composition and biological activities. The essential oil is rich in carvacrol, thymol, γ‐terpinene, and o‐cymene, while the aqueous and hydroethanolic extracts are characterized by poliumoside, verbascoside, isorhamnetin‐3‐O‐rutinoside, and apigenin‐7‐rutinoside. Antioxidant activity is
Hajar El Ouadni, Aziz Drioiche, Fadoua El Makhoukhi, Omkulthom Al kamaly, Hannou Zerkani, Smail Amalich, Imane Tagnaout, Mohamed Radi, Yahya Cherrah, Touriya Zair, Katim Alaoui   +10 more
wiley   +1 more source

Differential Characteristics and Comparison Between Long-COVID Syndrome and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). [PDF]

Biomedicines
Ivanovska M, Homadi MS, Angelova G, Taskov H, Murdjeva M.   +4 more
europepmc   +1 more source